Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.

Saadah NH, Schipperus MR, Wiersum-Osselton JC, van Kraaij MG, Caram-Deelder C, Beckers EAM, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, van der Bom JG.

Haematologica. 2019 Jul 4. pii: haematol.2019.222083. doi: 10.3324/haematol.2019.222083. [Epub ahead of print]

2.

Fatal Acute Hemolytic Transfusion Reaction due to Anti-Wra.

Bahri T, de Bruyn K, Leys R, Weerkamp F.

Transfus Med Hemother. 2018 Nov;45(6):438-441. doi: 10.1159/000488863. Epub 2018 Aug 24.

3.

[Diagnosis of haemochromatosis].

IJsselstijn L, van Houten AA, Weerkamp F.

Ned Tijdschr Geneeskd. 2017;161:D1438. Dutch.

PMID:
29145899
4.

Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.

Nijman RG, Vergouwe Y, Moll HA, Smit FJ, Weerkamp F, Steyerberg EW, van der Lei J, de Rijke YB, Oostenbrink R.

Pediatr Res. 2018 Feb;83(2):466-476. doi: 10.1038/pr.2017.216. Epub 2017 Nov 8.

PMID:
29116239
5.

Age of platelet concentrates and time to the next transfusion.

Caram-Deelder C, van der Bom JG, Putter H, Leyte A, Kerkhof DV, Evers D, Beckers EA, Weerkamp F, Hudig F, Zwaginga JJ, Rondeel JMM, de Vooght KMK, Péquériaux NCV, Visser O, Wallis JP, Middelburg RA.

Transfusion. 2018 Jan;58(1):121-131. doi: 10.1111/trf.14388. Epub 2017 Oct 31.

PMID:
29090466
6.

Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist.

Schellings MWM, de Maat MPM, de Lathouder S, Weerkamp F.

Clin Chem. 2017 Sep;63(9):1442-1444. doi: 10.1373/clinchem.2016.267245. No abstract available.

7.

Storage time of platelet concentrates and all-cause bacteremia in hematologic patients.

Kreuger AL, Middelburg RA, Bank CMC, Beckers EAM, van Gammeren AJ, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, Kerkhoffs JLH, van der Bom JG.

Transfusion. 2017 Sep;57(9):2096-2103. doi: 10.1111/trf.14194. Epub 2017 Jun 26.

PMID:
28653425
8.

C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.

Nijman RG, Moll HA, Smit FJ, Gervaix A, Weerkamp F, Vergouwe Y, de Rijke YB, Oostenbrink R.

Pediatr Infect Dis J. 2014 Nov;33(11):e273-9. doi: 10.1097/INF.0000000000000466.

PMID:
25093971
9.

Phagocytic plasma cells in a patient with smoldering myeloma.

Sayar Bahri T, Weerkamp F, Leys MB.

Int J Hematol. 2013 May;97(5):547-8. doi: 10.1007/s12185-013-1329-5. Epub 2013 Apr 21. No abstract available.

PMID:
23605438
10.

Left Shift 1+ flag for the detection of band neutrophils: interlaboratory variations and recommendations for the routine laboratory.

Weerkamp F, Taal PH, De Boer BA; ADdifVIA Working Group.

Int J Lab Hematol. 2011 Dec;33(6):601-9. doi: 10.1111/j.1751-553X.2011.01340.x. Epub 2011 Jun 16.

PMID:
21679309
11.

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.

Weerkamp F, Dekking E, Ng YY, van der Velden VH, Wai H, Böttcher S, Brüggemann M, van der Sluijs AJ, Koning A, Boeckx N, Van Poecke N, Lucio P, Mendonça A, Sedek L, Szczepański T, Kalina T, Kovac M, Hoogeveen PG, Flores-Montero J, Orfao A, Macintyre E, Lhermitte L, Chen R, Brouwer-De Cock KA, van der Linden A, Noordijk AL, Comans-Bitter WM, Staal FJ, van Dongen JJ; EuroFlow Consortium.

Leukemia. 2009 Jun;23(6):1106-17. doi: 10.1038/leu.2009.93. Epub 2009 Apr 23.

PMID:
19387467
12.

Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation.

Luis TC, Weerkamp F, Naber BA, Baert MR, de Haas EF, Nikolic T, Heuvelmans S, De Krijger RR, van Dongen JJ, Staal FJ.

Blood. 2009 Jan 15;113(3):546-54. doi: 10.1182/blood-2008-06-163774. Epub 2008 Oct 2.

13.

Wnt signaling and phosphorylation status of beta-catenin: importance of the correct antibody tools.

van Noort M, Weerkamp F, Clevers HC, Staal FJ.

Blood. 2007 Oct 1;110(7):2778-9. No abstract available.

14.

Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.

Pike-Overzet K, de Ridder D, Weerkamp F, Baert MR, Verstegen MM, Brugman MH, Howe SJ, Reinders MJ, Thrasher AJ, Wagemaker G, van Dongen JJ, Staal FJ.

Leukemia. 2007 Apr;21(4):754-63. Epub 2007 Feb 1.

PMID:
17268520
15.

Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program.

Weerkamp F, Luis TC, Naber BA, Koster EE, Jeannotte L, van Dongen JJ, Staal FJ.

Leukemia. 2006 Nov;20(11):1967-77. Epub 2006 Sep 21.

PMID:
16990763
16.

Gene therapy: is IL2RG oncogenic in T-cell development?

Pike-Overzet K, de Ridder D, Weerkamp F, Baert MR, Verstegen MM, Brugman MH, Howe SJ, Reinders MJ, Thrasher AJ, Wagemaker G, van Dongen JJ, Staal FJ.

Nature. 2006 Sep 21;443(7109):E5; discussion E6-7.

PMID:
16988660
17.

Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia.

Weerkamp F, van Dongen JJ, Staal FJ.

Leukemia. 2006 Jul;20(7):1197-205. Epub 2006 May 11. Review.

PMID:
16688226
18.

Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules.

Weerkamp F, Baert MR, Naber BA, Koster EE, de Haas EF, Atkuri KR, van Dongen JJ, Herzenberg LA, Staal FJ.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3322-6. Epub 2006 Feb 21.

19.

T-sing progenitors to commit.

Weerkamp F, Pike-Overzet K, Staal FJ.

Trends Immunol. 2006 Mar;27(3):125-31. Epub 2006 Feb 10. Review. Erratum in: Trends Immunol. 2007 Jul;28(7):293.

PMID:
16473042
20.

Effects of Delta1 and Jagged1 on early human hematopoiesis: correlation with expression of notch signaling-related genes in CD34+ cells.

Neves H, Weerkamp F, Gomes AC, Naber BA, Gameiro P, Becker JD, Lúcio P, Clode N, van Dongen JJ, Staal FJ, Parreira L.

Stem Cells. 2006 May;24(5):1328-37. Epub 2006 Jan 12.

21.

Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential.

Weerkamp F, Baert MR, Brugman MH, Dik WA, de Haas EF, Visser TP, de Groot CJ, Wagemaker G, van Dongen JJ, Staal FJ.

Blood. 2006 Apr 15;107(8):3131-7. Epub 2005 Dec 29.

22.

New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling.

Dik WA, Pike-Overzet K, Weerkamp F, de Ridder D, de Haas EF, Baert MR, van der Spek P, Koster EE, Reinders MJ, van Dongen JJ, Langerak AW, Staal FJ.

J Exp Med. 2005 Jun 6;201(11):1715-23. Epub 2005 May 31.

23.

Age-related changes in the cellular composition of the thymus in children.

Weerkamp F, de Haas EF, Naber BA, Comans-Bitter WM, Bogers AJ, van Dongen JJ, Staal FJ.

J Allergy Clin Immunol. 2005 Apr;115(4):834-40.

PMID:
15806007
24.

Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA.

J Exp Med. 2004 Mar 1;199(5):687-95.

25.

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.

Baum C, von Kalle C, Staal FJ, Li Z, Fehse B, Schmidt M, Weerkamp F, Karlsson S, Wagemaker G, Williams DA.

Mol Ther. 2004 Jan;9(1):5-13. Review.

26.

Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion.

Staal FJ, Weerkamp F, Baert MR, van den Burg CM, van Noort M, de Haas EF, van Dongen JJ.

J Immunol. 2004 Jan 15;172(2):1099-108.

27.

Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development.

Taghon T, Thys K, De Smedt M, Weerkamp F, Staal FJ, Plum J, Leclercq G.

Leukemia. 2003 Jun;17(6):1157-63.

PMID:
12764384
28.

Transcriptional control of t lymphocyte differentiation.

Staal FJ, Weerkamp F, Langerak AW, Hendriks RW, Clevers HC.

Stem Cells. 2001;19(3):165-79. Review.

Supplemental Content

Loading ...
Support Center